仙樂健康(300791.SZ)與易簡投資擬共設產業投資基金 投向優質大健康項目
格隆匯1月3日丨仙樂健康(300791.SZ)公佈,仙樂健康與廣東易簡投資有限公司(“易簡投資”)擬簽署《廣州仙樂易簡健康產業投資合夥企業(有限合夥)合夥協議》,共同投資設立廣州仙樂易簡健康產業投資合夥企業(有限合夥)(名稱以工商登記為準,下稱“基金”或“合夥企業”),基金規模總計20001萬元人民幣,以現金方式分兩期繳付。首期出資規模為10001萬元人民幣,其中,公司以自有資金認繳基金首期出資10000萬元人民幣,佔基金出資總額比例99.99%,繫有限合夥人;易簡投資合計認繳基金首期出資1萬元人民幣,佔基金出資總額比例0.01%,系普通合夥人。首期出資認繳後,其餘出資規模可由易簡投資和仙樂健康於其後繼續認繳,或引入其他投資人認繳。基金擬投向與公司主營業務相關的優質大健康項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.